breast neoplasms

Showing NaN - NaN of 41

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Breast Tumors Trial in Spain (No intervention)

Recruiting
  • Breast Neoplasms
  • No intervention
  • Elche, Alicante, Spain
  • +39 more
Jan 20, 2023

Breast Tumors Trial in Worldwide (Abemaciclib, Standard Adjuvant ET, Placebo)

Active, not recruiting
  • Breast Neoplasms
  • Daphne, Alabama
  • +176 more
Jan 18, 2023

Breast Tumors, Breast Cancer, HER2-positive Early Breast Cancer Trial in Worldwide (Trastuzumab Deruxtecan, Paclitaxel,

Recruiting
  • Breast Neoplasms
  • +2 more
  • Trastuzumab Deruxtecan
  • +5 more
  • Springdale, Arkansas
  • +203 more
Jan 13, 2023

Breast Tumors Trial in Worldwide (Xentuzumab, Placebo, Everolimus)

Completed
  • Breast Neoplasms
  • Chandler, Arizona
  • +53 more
Dec 13, 2022

Breast Tumors Trial in Worldwide (PD-0332991, Letrozole, Placebo)

Active, not recruiting
  • Breast Neoplasms
  • Bellflower, California
  • +304 more
Dec 6, 2022

Breast Tumors Trial in Worldwide (Abemaciclib, Fulvestrant, Placebo)

Active, not recruiting
  • Breast Neoplasms
  • Fayetteville, Arkansas
  • +141 more
Nov 15, 2022

Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Exemestane)

Completed
  • Breast Neoplasms
  • Radium-223 dichloride (Xofigo, BAY88-8223)
  • +3 more
  • Yuma, Arizona
  • +93 more
Nov 4, 2022

Breast Tumors Trial in Worldwide (Imlunestrant, Tamoxifen, Anastrozole)

Not yet recruiting
  • Breast Neoplasms
  • Jonesboro, Arkansas
  • +330 more
Aug 23, 2022

Breast Tumors, Tumor Metastasis Trial in Worldwide (Imlunestrant, Exemestane, Fulvestrant)

Recruiting
  • Breast Neoplasms
  • Neoplasm Metastasis
  • Chandler, Arizona
  • +238 more
Aug 17, 2022

Breast Tumors Trial in Worldwide (pembrolizumab, paclitaxel, nab-paclitaxel)

Recruiting
  • Breast Neoplasms
  • pembrolizumab
  • +6 more
  • Tucson, Arizona
  • +188 more
Aug 11, 2022

Quality of Life in Metastatic Breast Cancer Second Line

Completed
  • Breast Neoplasms
    • Huelva, Andalucía, Spain
    • +28 more
    Jun 29, 2022

    Breast Cancer, Breast Tumors, Quality of Life Trial in Barcelona (Xemio mobile application)

    Recruiting
    • Breast Cancer
    • +3 more
    • Xemio mobile application
    • Barcelona, Catalonia, Spain
      Hospital Clínic
    Jun 3, 2022

    Breast Tumors Trial in Barcelona (Cyclophosphamide, Trastuzumab, Pertuzumab)

    Recruiting
    • Breast Neoplasms
    • Barcelona, Spain
    • +1 more
    May 31, 2022

    Breast Tumors Trial in Worldwide (Herceptin)

    Completed
    • Breast Neoplasms
    • Tirana, Albania
    • +436 more
    Apr 26, 2021

    Breast Tumors Trial in Worldwide (Ipatasertib, Paclitaxel, Placebo)

    Completed
    • Breast Neoplasms
    • Fullerton, California
    • +43 more
    Feb 18, 2021

    Breast Tumors Trial in Worldwide (Lapatinib, Letrozole, Placebo)

    Completed
    • Breast Neoplasms
    • Tucson, Arizona
    • +277 more
    Feb 8, 2021

    Tumors, Breast Tumors, Kidney Tumors Trial in Worldwide (alpelisib, everolimus, exemestane)

    Completed
    • Neoplasms
    • +3 more
    • Fayetteville, Arkansas
    • +21 more
    Dec 4, 2020

    Breast Tumors Trial in Worldwide (Docetaxel, Nab-paclitaxel, Paclitaxel)

    Completed
    • Breast Neoplasms
    • Algiers, Algeria
    • +298 more
    Aug 31, 2020

    Breast Tumors Trial in Worldwide (Radium-223 dichloride (Xofigo, BAY88-8223), Placebo (saline), Background hormonal therapy)

    Terminated
    • Breast Neoplasms
    • Radium-223 dichloride (Xofigo, BAY88-8223)
    • +2 more
    • Bakersfield, California
    • +70 more
    Jul 29, 2020

    Breast Tumors Trial in Ireland, Spain (PD-0332991 (Palbociclib), Fulvestrant, Placebo)

    Active, not recruiting
    • Breast Neoplasms
    • PD-0332991 (Palbociclib)
    • +2 more
    • Cork, Ireland
    • +31 more
    Feb 3, 2020

    Breast Tumors, BRCA 1 Gene Mutation, BRCA 2 Gene Mutation Trial in Worldwide (talazoparib)

    Terminated
    • Breast Neoplasms
    • +2 more
    • Greenbrae, California
    • +70 more
    Oct 10, 2019

    Breast Tumors Trial in Worldwide (BIBW 2992, trastuzumab, vinorelbine)

    Completed
    • Breast Neoplasms
    • BIBW 2992
    • +2 more
    • Birmingham, Alabama
    • +206 more
    Jul 4, 2019